AbbVie (ABBV) Q2 2025 Earnings Call Transcript

Powered byQuartr

Company Participants

  • Operator
  • Liz Shea - Head, IR, AbbVie
  • Robert Michael - CEO & Chairman of Board, AbbVie
  • Jeffrey Stewart - EVP & Chief Commercial Officer, AbbVie
  • Roopal Thakkar - EVP - R&D & Chief Scientific Officer, AbbVie
  • Scott Reents - EVP & CFO, AbbVie
  • Mohit Bansal - Managing Director, Wells Fargo Securities
  • Terence Flynn - Equity Research Analyst, Morgan Stanley
  • Chris Schott - Managing Director, JP Morgan
  • David Risinger - Senior Managing Director, Biopharma, Leerink Partners
  • Carter Gould - MD & Senior Analyst, Cantor Fitzgerald
  • Tim Anderson - Managing Director, Senior Equity Research Analyst, Bank of America
  • Vamil Divan - MD & Senior Research Analyst, Guggenheim Securities, LLC
  • Steve Scala - Pharmaceutical Analyst, TD Cowen
  • Trung Huynh - Executive Director & Equity Research, UBS Group
  • Gary Nachman - MD - BioPharma/Biotech Equity Research Analyst, Raymond James Financial
  • Asad Haider - Equity Research Analyst, Goldman Sachs